Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Lung Cancer (Diagnosis) clinical trials
6 of 7 indexed Lung Cancer (Diagnosis) trials are currently recruiting.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Lung Cancer (Diagnosis): 7 US clinical trials tracked, 6 recruiting.
Lung Cancer (Diagnosis) is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. The most active sponsor is Freenome Holdings, running 1 of these trials.
Enrollment posture brief
Registry condition lung-cancer-diagnosis
OPEN 6 | RECR 86% | LATE 0 | EARLY 0 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenovirus (86% recruiting · 7 trials)
Lung Cancer (Diagnosis) lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Lung Cancer (Diagnosis) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Lung Cancer (Diagnosis) is recruiting above its size-band peers.
6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Lung Cancer (Diagnosis) trials is spread across many organizations.
Freenome Holdings accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Lung Cancer (Diagnosis) enrolment sits around 1,800 participants.
Median target enrolment is 1,800 among the 7 trials that report a genuine target (sentinel values excluded). 1 of those (14.3%) plan for fewer than 100 participants.
-
Lung Cancer (Diagnosis) splits between interventional and observational designs.
3 interventional and 4 observational studies make up this index (42.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Freenome Holdings
NCT06122077
Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
bioAffinity Technologies
NCT07168993
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
NYU Langone Health
NCT06559059
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
AdventHealth
NCT07231159
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
Barbara Nemesure
NCT07161713
Telehealth Collaborative Care Model (CoCM) in Lung Cancer
Abramson Cancer Center at Penn Medicine
NCT07102147
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
Exact Sciences Corporation
NCT03633006
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Lung Cancer (Diagnosis) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Lung Cancer (Diagnosis) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Lung Cancer (Diagnosis) page
7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Lung Cancer (Diagnosis) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Freenome Holdings sponsors the most Lung Cancer (Diagnosis) trials on record, review their full trial history before evaluating a specific study. See Freenome Holdings's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Lung Cancer (Diagnosis) condition card totals 7 registered trials; most-linked intervention Blood Sample Collection; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.